phase II clinical study Aug 27, 2020 Natera, MGH to Collaborate in Early-Stage Breast Cancer Clinical Trial of Targeted Therapy Aug 13, 2020 Strata, Mirati Therapeutics Partner on Tumor-Agnostic Clinical Trial of Novel KRAS G12C Inhibitor Feb 11, 2020 Natera, Elicio Therapeutics Partner on Phase I/II Pancreatic Cancer Study May 6, 2019 FDA Grants IDE Approval for Almac Diagnostic Services' CDx for Use in Cancer Drug Study Breaking News Rady Children's, PlumCare RWE Partner to Expand WGS-Based Newborn Screening Program to Greece Roche Gets CE Mark for New Version of Rapid Test for Antibodies Against SARS-CoV-2 Broader Market Drags 360Dx Top 30 Down in September Olive Diagnostics Nabs CE Mark for Optical Urinalysis Device Top Five Articles on 360Dx Last Week: Congress and VALID Act; FDA Updates EUA Policy; and More In Brief This Week: Becton Dickinson, Bionano, Yourgene, More
